The Effect of Fact Versus Myth Messages on Receipt of Influenza Vaccination

NCT ID: NCT01009645

Last Updated: 2023-10-30

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

125 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-09-30

Study Completion Date

2010-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate whether message design of educational materials increases vaccination rates among participants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Influenza Vaccination

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fact Only

The educational message used will contain facts only.

Group Type EXPERIMENTAL

Fact Only Education Message

Intervention Type BEHAVIORAL

Participants randomized to this intervention will receive an educational brochure listing the facts of the influenza vaccine.

Fact and Myth

The educational material seen by this arm will contain facts and myths only.

Group Type EXPERIMENTAL

Fact and Myth Educational Message

Intervention Type BEHAVIORAL

Participants randomized to this intervention will receive an educational brochure listing the facts and myths of the influenza vaccine.

Fact, Myth, Why

The educational material seen by this arm will contain myths, facts, and refutations of the myths.

Group Type EXPERIMENTAL

Fact, Myth, Why Educational Message

Intervention Type BEHAVIORAL

Participants randomized to this intervention will receive an educational brochure listing the facts, myths, and refutation of the myths of the influenza vaccine.

Control

This arm will receive fact/myth educational materials originally developed and used by the CDC.

Group Type PLACEBO_COMPARATOR

Control Educational Message

Intervention Type BEHAVIORAL

Participants randomized to this intervention will receive an educational brochure created and used by the CDC in a previous influenza season.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fact Only Education Message

Participants randomized to this intervention will receive an educational brochure listing the facts of the influenza vaccine.

Intervention Type BEHAVIORAL

Fact and Myth Educational Message

Participants randomized to this intervention will receive an educational brochure listing the facts and myths of the influenza vaccine.

Intervention Type BEHAVIORAL

Fact, Myth, Why Educational Message

Participants randomized to this intervention will receive an educational brochure listing the facts, myths, and refutation of the myths of the influenza vaccine.

Intervention Type BEHAVIORAL

Control Educational Message

Participants randomized to this intervention will receive an educational brochure created and used by the CDC in a previous influenza season.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Fact Only Fact & Myth Fact, Myth, Why Control

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participant must have a scheduled appointment at least 6 weeks in advance in either the GIM or Geriatrics clinics at NMFF.
* Participant must be a patient of Northwestern Medical Faculty Foundation.
* Participant does not intend to receive the influenza vaccine.

Exclusion Criteria

* Participant has a diagnosis of Alzheimer's Disease or Dementia
* Participant has received an influenza vaccination during either the last influenza season or the current.
* The scheduled visit is the participant's first time being seen by this doctor (appointment is to establish care in the clinic).
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Aging (NIA)

NIH

Sponsor Role collaborator

Northwestern University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Northwestern Medical Faculty Foundation General Internal Medicine and Geriatric Clinics

Chicago, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R21AG031470-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

Fact versus Myth Messages

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Flu Shot Pre-visit Questionnaire
NCT05508698 COMPLETED NA
Body and Social Behavior
NCT05654441 COMPLETED PHASE4
SAVE: School Ambassadors for Vaccine Education
NCT07164144 NOT_YET_RECRUITING NA
High-risk Influenza Vaccine Alert
NCT05492786 COMPLETED NA